Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04505618 · ClinicalTrials.gov registry record · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
A NA study of Diabetic Retinopathy and Retinal Vein Occlusion, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,050
- Enrollment target
- 1
- Study location
NCT04505618: Recruiting NA study of Diabetic Retinopathy and Retinal Vein Occlusion, sponsored by Johns Hopkins University.
NCT04505618 is a NA study of Diabetic Retinopathy and Retinal Vein Occlusion that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 1,050 participants, below the 1,658-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04505618, a NA study of Diabetic Retinopathy and Retinal Vein Occlusion, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,050 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.
Primary Outcome
Correlation of diagnostic imaging findings (vessel skeleton density) from OCT based images with disease stage
Conditions Studied
Interventions
- DEVICE Swept-Source (SS) OCT Angiography
- DEVICE Spectral-Domain (SD) OCT Angiography
- DEVICE Fundus Imaging
- DEVICE Axial Length Measurement Device
Study Locations (1)
Maryland
- Wilmer Eye Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,050 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What NCT04505618 shows while recruiting
NCT04505618 is an interventional study that assigns participants to a tested intervention. Its 1,050 participants enrollment target places it among the larger protocols in the corpus, below the 1,658-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (37% lower).
The record links to 4 conditions, with Diabetic Retinopathy appearing as the primary indexed condition, and to 4 interventions - of which Swept-Source (SS) OCT Angiography is the first listed.
NCT04505618 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04505618 about?
NCT04505618 is a clinical study titled "Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease". This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of di...
What is the current status of trial NCT04505618?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,050 participants. The study started on 2019-10-01. Estimated completion is 2026-09-01.
What conditions does trial NCT04505618 study?
This clinical trial studies the following conditions: Diabetic Retinopathy, Retinal Vein Occlusion, Hypertension,Essential, Retinal Vascular Disorder.
What interventions are being tested in trial NCT04505618?
The interventions under investigation include: Swept-Source (SS) OCT Angiography (DEVICE), Spectral-Domain (SD) OCT Angiography (DEVICE), Fundus Imaging (DEVICE), Axial Length Measurement Device (DEVICE).
Who is sponsoring clinical trial NCT04505618?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04505618 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04505618's enrollment target sits among peer trials
1,050 6th of 57 higher than 52 of 57 other Diabetic Retinopathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Retinopathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Implementation of Teleophthalmology in Urban Health Systems Study
ACTIVE NOT RECRUITING · NA
-
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
ACTIVE NOT RECRUITING · NA
-
Circadian Amplification in Diabetic Retinopathy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511806 · 1,050 participants
Childhood Cancer Predisposition Study (CCPS)
- NCT05028972 · 1,050 participants · NA
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
- NCT05915377 · 1,050 participants · NA
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
- NCT05958342 · 1,050 participants · Phase 2
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI